S. Kitov

Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.

N. Haigwood, D. Montefiori, P. Johnson, 1992, Proceedings of the National Academy of Sciences of the United States of America.

The effect of cis-platin analogues derived from aminoalkylaminoanthraquinones on DNA cleavage: an electron microscopy study

J. Katzhendler, D. Gibson, I. Ringel, 1988 .

Fermentation and Post‐Fermentation Changes in Israeli Wines

A. Goldblum, S. Gorinstein, J. Deutsch, 1984 .

Purification, Characterization, and Immunogenicity of the Refolded Ectodomain of the Plasmodium falciparum Apical Membrane Antigen 1 Expressed in Escherichia coli

J. K. Moch, J. Haynes, D. Lanar, 2002, Infection and Immunity.

Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.

S. Hoffman, A. Krieg, H. Davis, 1999, Vaccine.

Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli.

J. Sacci, P. de la Vega, D. Lanar, 2001, Journal of chromatography. B, Biomedical sciences and applications.

The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques.

P. Johnson, V. Hirsch, S. Goldstein, 1991, Virology.

Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells.

N. Haigwood, D. Montefiori, P. Johnson, 1992, AIDS research and human retroviruses.

Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants.

S. Hoffman, R. Hunter, J. Sacci, 1998, Vaccine.